What is Reactive Arthritis?
Reactive arthritis is an autoimmune condition that was first described by a German military physician Hans Reiter in 1918. He discovered this disease as he was examining a World War I Prussian soldier who was recuperating from a bout of diarrhea. The three characteristic features he described included - inflammation of the joints, urinary tract, and eyes. Since then doctors have identified a fourth major feature - ulcerations of the skin and mouth.
Some of the other disorders associated with Reactive Arthritis are ankylosing spondylitis, psoriatic arthritis, and inflammatory bowel syndrome. Reactive Arthritis may be acute in the vast majority of affected individuals in whom the condition will resolve on its own in a period of one year. In some it may recur frequently for many years and this will lead to the condition becoming chronic.
Most cases involve adults in their forties. One fifth of the women are affected as often as men and when it occurs, women get the post -dysenteric form of the disease. They are less likely to have the arthritic symptoms. The sexually transmitted form is more prevalent among sexually active young men. The disease is a rarity among Black males. People affected by Reactive Arthritis have the potential to enjoy a normal span of life thanks to lifestyle modifications and excellent treatments available. Early diagnosis of the patient is important to prevent the development of arthritic complications.
Latest Publications and Research on Reactive ArthritisFoot function in rheumatoid arthritis patients: a cross-sectional study. - Published by PubMed
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial. - Published by PubMed
Effectiveness and safety of initiating adalimumab plus =12?mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan. - Published by PubMed
Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome. - Published by PubMed
ACPA mediates the interplay between innate and adaptive immunity in rheumatoid arthritis. - Published by PubMed